Managing Director, FasterCures, Milken Institute Health
Sung Hee Choe is the managing director on the FasterCures team at the Milken Institute. She oversees the programmatic portfolio and is responsible for day-to-day operations.
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
Cell and gene therapies are a new category of medicines transforming how we treat and potentially cure disease. Both cell and gene therapies seek to modify genetic material to fight disease. Cell therapies involve cultivating or modifying cells outside the body before injecting them into a patient. Gene therapies use genetic material to manipulate the expression of a gene or alter the properties of an individual’s cells.
Today, seven cell and gene therapies are approved for marketing in the US and fewer than 10 are approved in Europe. Dozens of new cell and gene therapies are expected to become available in the US in the coming years. According to recent research, more than 1,000 cell and gene therapies are currently in development, with 50–75 therapies expected to be approved in the US by 2030.
In response to this growing pipeline and the hope these therapies offer, FasterCures convened roundtables and discussions to bring to light the unique regulatory and access considerations posed by cell and gene therapies. On November 3, 2021, FasterCures brought together its stakeholder community, along with Peter Marks, director of CBER at FDA, in a virtual roundtable. The goals of the roundtable included taking stock of the current status of cell and gene therapies given the disruptions caused by the COVID-19 pandemic, and identifying opportunities for collective engagement in 2022.
This report summarizes the key takeaways from the November 3 roundtable, and considers the developments that will take place in cell and gene therapies in 2022.
LOS ANGELES, Tuesday, October 30, 2018—The impact of obesity and overweight on the U.S. economy has eclipsed $1.7 trillion, an amount equivalent to 9.3 percent of the nation’s gross domestic product, according to a new Milken Institute...
Responding to COVID-19: Conversations with Mike Milken features medical research, business, and public policy leaders LOS ANGELES, April 7, 2020 – The Milken Institute today introduced a new program focusing on leaders in the war against...
Mike Milken, chairman of the Milken Institute, has been at the forefront of successful initiatives in medical research, education, public health and access to capital for more than four decades. Fortune called him “The Man Who Changed Medicine” and Forbes listed him among “Visionaries Reimagining Our Children’s Future.”
Witness List Keith R. Yamamoto, Ph.D. Vice Chancellor for Science Policy and Strategy, University of California San Francisco Esther Krofah, Executive Director, FasterCures and Center for Public Health at the Milken Institute Geoffrey Shiu...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
WASHINGTON, DC (November 14, 2023) — The Kissick Family Foundation Frontotemporal Dementia Grant Program, in partnership with the Milken Institute, launched its first-ever request for funding proposals today. Up to $2.5 million in total...
Chad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events.
Best Cities for Successful Aging is a first-of-its-kind, data-driven index that measures and ranks the performance of 352 U.S. metropolitan areas in promoting and enabling successful aging. Unlike many “best places to retire” lists, the...
Language matters. At a February 2016 workshop of leaders committed to expanding patient engagement hosted by FasterCures, just 22 percent felt there was broad agreement on what the term “patient-centered” means or represents. The need to...
The Listening Project is a research program developed by the Milken Institute and The Harris Poll to understand the most urgent needs and challenges people are facing globally. For the second edition of our annual study, we asked nearly 17...
The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental and environmental health, we bring together the best ideas...
This report covers the alarming reality of maternal mortality in the United States, where the maternal mortality ratio (number of maternal deaths per 100,000 births) stands as one of the highest among Organisation for Economic Co-operation...
WASHINGTON, DC (April 30, 2024) — Tambourine Philanthropies (Tambourine), in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is pleased to announce the recipients of its ALS...
The Interagency Coordinating Committee on Healthy Aging and Age-Friendly Communities Administration for Community Living US Department of Health and Human Services Washington, DC 20201 Dear Interagency Coordinating Committee on Healthy...
Michelle Tarver, MD, PhD Director, Center for Devices and Radiological Health US Food and Drug Administration Silver Spring, MD 20993 Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research US Food and Drug...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
